Page 14 of 20 – SEC Filing D. LCSL (a) As the General Partner of Trilogy, LCSL is deemed to beneficially own the 51,068 Shares beneficially owned by Trilogy. Percentage: Less than 1.0%. (b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 51,068 * 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 51,068 * * As the general partner to Trilogy, LCSL has shared voting and dispositive power over these Shares. As the investment advisor to Trilogy, LCS has shared voting and dispositive power over these Shares. (c) LCSL has not undertaken any transactions in the Shares during the past 60 days. The transactions in the Shares by Trilogy during the past 60 days are set forth in Schedule A and are incorporated herein by reference. E. Levcap (a) As of the close of business on October 14, 2016, Levcap beneficially owned 22,453 Shares. Percentage: Less than 1.0%. (b) 1. Sole power to vote or direct vote: 0 2. Shared power to vote or direct vote: 22,453 * 3. Sole power to dispose or direct the disposition: 0 4. Shared power to dispose or direct the disposition: 22,453* * As the general partner to Levcap, LCSEP has shared voting and dispositive power over these Shares. As the investment advisor to Levcap, LCS has shared voting and dispositive power over these Shares. (c) The transactions in the Shares by Levcap during the past 60 days are set forth in Schedule A and are incorporated herein by reference.
D. LCSL
(a) As the General Partner of Trilogy, LCSL is deemed to beneficially own the 51,068 Shares beneficially owned by Trilogy.
Percentage: Less than 1.0%.
(b) 1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 51,068 *
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 51,068 *
* As the general partner to Trilogy, LCSL has shared voting and dispositive power over these Shares. As the investment advisor to Trilogy, LCS has shared voting and dispositive power over these Shares.
(c) LCSL has not undertaken any transactions in the Shares during the past 60 days. The transactions in the Shares by Trilogy during the past 60 days are set forth in Schedule A and are incorporated herein by reference.
E. Levcap
(a) As of the close of business on October 14, 2016, Levcap beneficially owned 22,453 Shares.
Percentage: Less than 1.0%.
(b) 1. Sole power to vote or direct vote: 0
2. Shared power to vote or direct vote: 22,453 *
3. Sole power to dispose or direct the disposition: 0
4. Shared power to dispose or direct the disposition: 22,453*
* As the general partner to Levcap, LCSEP has shared voting and dispositive power over these Shares. As the investment advisor to Levcap, LCS has shared voting and dispositive power over these Shares.
(c) The transactions in the Shares by Levcap during the past 60 days are set forth in Schedule A and are incorporated herein by reference.
Follow Standard Biotools Inc. (NASDAQ:LAB)
Follow Standard Biotools Inc. (NASDAQ:LAB)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
